These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 590905)

  • 1. [Beta-sitosterin in the treatment of essential type II hyperlipoproteinemias].
    Kaffarnik H; Mühlfellner G; Mühlfellner O; Schneider J; Hausmann L; Zöfel P; Schubotz R; Fuchs F
    Fortschr Med; 1977 Dec; 95(46):2785-7. PubMed ID: 590905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Beta-sitosterin in unsuccessfully pretreated patients with hypercholesteremia. Simultaneously, a contribution to dose dependence].
    Mühlfellner G; Mühlfellner O; Kaffarnik H
    Med Klin; 1976 Apr; 71(18):775-8. PubMed ID: 178987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dose-effect of beta-sitosterin in type IIa and IIb hypercholesterolemias (author's transl)].
    Schwartzkopff W; Jantke HJ
    MMW Munch Med Wochenschr; 1978 Nov; 120(47):1575-8. PubMed ID: 214701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sitosterol in familial hyperlipoproteinemia type II. A randomized double-blind cross-over study].
    Oster P; Schlierf G; Heuck CC; Greten H; Gundert-Remy U; Haase W; Klose G; Nothelfer A; Raetzer H; Schellenberg B; Schmidt-Gayk H
    Dtsch Med Wochenschr; 1976 Sep; 101(36):1308-11. PubMed ID: 182445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a stanol-enriched diet on plasma cholesterol and triglycerides in patients treated with statins.
    Castro Cabezas M; de Vries JH; Van Oostrom AJ; Iestra J; van Staveren WA
    J Am Diet Assoc; 2006 Oct; 106(10):1564-9. PubMed ID: 17000189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of familial type II hyperlipoproteinemia in adults and children by means of sitosterin].
    Oster P; Schlierf G; Heuck CC; Greten H; Gundert-Remy U; Haase W; Klose G; Nothhelfer A; Raetzer H; Schellenberg B; Schmidt Gayk H
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():824-5. PubMed ID: 1029293
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
    Arntz HR; Klemens UH; Vollmar LJ; Lang PD
    Med Klin; 1978 Dec; 73(49):1731-7. PubMed ID: 723760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of severe familial hypercholesterolemia in children: effect of sitosterol and bezafibrate.
    Becker M; Staab D; Von Bergman K
    Pediatrics; 1992 Jan; 89(1):138-42. PubMed ID: 1727999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sitosterol in juvenile type II hyperlipoproteinemia.
    Schlierf G; Oster P; Heuck CC; Raetzer H; Schellenberg B
    Atherosclerosis; 1978 Aug; 30(4):245-8. PubMed ID: 213081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipoproteins and lecithin: cholesterol acyltransferase (LCAT) activity in hypercholesterolemic subjects given beta-sitosterol.
    Weisweiler P; Heinemann V; Schwandt P
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):204-6. PubMed ID: 6715090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal plasma concentrations of plant sterols can predict LDL-C response to sitosterol in patients with familial hypercholesterolemia.
    Fuentes F; López-Miranda J; García A; Pérez-Martínez P; Moreno J; Cofan M; Caballero J; Paniagua JA; Ros E; Pérez-Jiménez F
    Eur J Clin Nutr; 2008 Apr; 62(4):495-501. PubMed ID: 17440528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of lovastatin on serum lipids in patients with primary hyperlipidemia phenotype IIa and IIb. I. Efficacy of lovastatin in the treatment of hyperlipoproteinemia].
    Idzior-Waluś B
    Przegl Lek; 1992; 49(9):287-91. PubMed ID: 1302351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta sitosterin in hypercholesterinemia].
    Etminan K; Gau HP; Kanokvichitra SC; Eickenbusch W
    ZFA (Stuttgart); 1979 Sep; 55(27):1503-6. PubMed ID: 483994
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of dyslipidaemia with a simple low fat diet and with a combination of a low fat diet and a formulation containing soybean protein.
    Pesciatini F; Cefis M; Lazzaroni A; Pansera P; Cerri B
    Int J Clin Pharmacol Res; 1985; 5(3):199-204. PubMed ID: 4018955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plafibride treatment and serum lipids in hyperlipoproteinemias.
    Rodriguez F; López IM; Jover E
    J Med; 1987; 18(3-4):153-63. PubMed ID: 3323393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effect of dietary sitosterol on plasma sterols and cholesterol and bile acid synthesis in a sitosterolemic homozygote and heterozygote subject.
    Cobb MM; Salen G; Tint GS
    J Am Coll Nutr; 1997 Dec; 16(6):605-13. PubMed ID: 9430090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activity in vivo in hyperlipoproteinemia--importance of combined hyperlipidemia.
    Bröijersén A; Hamsten A; Eriksson M; Angelin B; Hjemdahl P
    Thromb Haemost; 1998 Feb; 79(2):268-75. PubMed ID: 9493574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
    Domingo AJ; Gutiérrez JA; Menéndez JA; Micó L; Muñoz M; de Oya M
    Clin Ther; 1980; 3(3):219-26. PubMed ID: 7459931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
    Lopez Rodriguez J; Martorell J
    Clin Ther; 1980; 3(4):234-41. PubMed ID: 7273061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)].
    Koschinsky T; Lenhard P; Gries FA; Vogelberg KH; Wolfram G; Lang PD; Vollmar J
    Med Klin; 1977 Sep; 72(38):1537-43. PubMed ID: 904549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.